Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...